MTAP cooperative PRMT5 inhibitor

Search documents
Tango Therapeutics (TNGX) 2025 Conference Transcript
2025-09-03 19:45
Tango Therapeutics (TNGX) 2025 Conference September 03, 2025 02:45 PM ET Speaker0Okay. Good afternoon, everyone, and welcome back to the Cantor conference. We're on time here, so we're going to get started. My name is Eric Schmidt. I'm one of the analysts at the firm, and it is my pleasure to welcome Tango Therapeutics today.And Barbara Weber, the company's Chief Executive Officer, will be sharing this fireside chat with me. We also have in the audience Adam Christel, the company's President and Head of R a ...